Amphastar Pharmaceuticals AMPH Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's short-term investments?
- Amphastar Pharmaceuticals (AMPH) reported short-term investments of $121.01M in Q1 2026.
- How has Amphastar Pharmaceuticals's short-term investments changed year-over-year?
- Amphastar Pharmaceuticals's short-term investments increased by 123.7% year-over-year, from $54.1M to $121.01M.
- What is the long-term trend for Amphastar Pharmaceuticals's short-term investments?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's short-term investments has grown at a 54.1% compound annual growth rate (CAGR), from $12.98M to $112.64M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.